Cargando…
Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model
Doxorubicin (Doxo) is the most effective chemotherapeutic agent for the treatment of breast cancer. However, resistance to Doxo is common. Adjuvant compounds capable of modulating mechanisms involved in Doxo resistance may potentiate the effectiveness of the drug. Resveratrol (Rsv) has been tested a...
Autores principales: | Vargas, José Eduardo, Puga, Renato, Lenz, Guido, Trindade, Cristiano, Filippi-Chiela, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654215/ https://www.ncbi.nlm.nih.gov/pubmed/33204396 http://dx.doi.org/10.1155/2020/5432651 |
Ejemplares similares
-
Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma Cells
por: Filippi-Chiela, Eduardo C., et al.
Publicado: (2011) -
Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in HCT116 colon cancer cell
por: Park, Dong-Guk
Publicado: (2014) -
Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats
por: Yang, Dong Kwon, et al.
Publicado: (2018) -
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
por: Filippi-Chiela, Eduardo C, et al.
Publicado: (2013) -
Single-cell analysis challenges the connection between autophagy and senescence induced by DNA damage
por: Filippi-Chiela, Eduardo Cremonese, et al.
Publicado: (2015)